Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Building on Accomplishments

E. William St.Clair, MD  |  December 1, 2009

As I assume the presidency of the REF, I reflect on the accomplishments of the organization over the past two years, and I wish to thank my immediate predecessor, Leslie J. Crofford, MD, for her tremendous leadership. The achievements of the REF during her term have been truly impressive.

A Preceptorship Comes Full Circle

Staff  |  December 1, 2009

Ephraim P. Engleman, MD, has spent his career drawing attention to the field of rheumatology. Widely regarded as one of the founders of the modern practice of rheumatology, this 98-year-old director of the Rosalind Russell Medical Research Center for Arthritis at the University of California, San Francisco (UCSF), is still working hard at promoting the field.

Doctor or Accountant?

Stanley B. Cohen, MD  |  December 1, 2009

Complex coding and reimbursement rules can detract from patient care

Medicare Bills Under the Magnifying Glass

Christopher Guadagnino, PhD  |  December 1, 2009

What you need to know about the Recovery Audit Contractor program

Sex Differences & Rheumatoid Arthritis

Tuulikki Sokka, MD, PhD  |  December 1, 2009

The beliefs versus the data

Chance Discovery May Provide RA Diagnostic

Sue Pondrom  |  November 1, 2009

Science From Arthritis & Rheumatism

PAC Progress and Challenges

David Holzman  |  November 1, 2009

After three years, RheumPAC has a solid start, and more work ahead of it

Members, Submitters Share Thoughts on ACR Journals

Robert I. Fox, MD, PhD, and Carla M. Fox, RN  |  November 1, 2009

In an online survey conducted in the spring of 2009, the ACR collected information on journal readership patterns, satisfaction, and content interests. The survey was sent to a sample of ACR and ARHP members who had not submitted manuscripts to Arthritis & Rheumatism (A&R) or Arthritis Care & Research (AC&R) within a recent 12-month period. It was also sent, with additional questions regarding submission and review, to all members and nonmembers who had submitted at least one manuscript to either journal during the 12-month period. Because of the international scope and reputation of the ACR journals, along with the fact that most members are in clinical practice and do not generally conduct and publish research, 63% of the submitters to the journals are not members of the ACR or ARHP. The ACR journals have long been viewed as the place where both members and nonmembers seek to publish their high-quality work.

RheumPAC Supports Two Candidates Who Support Rheumatology

Staff  |  November 1, 2009

RheumPAC, the ACR’s political action committee (PAC), ensures that the ACR is involved in healthcare reform discussions. RheumPAC representatives have been busy attending fundraisers and educating key congressional members on the ACR’s legislative priorities.

Your Patients Can Make a Difference—Get Them Involved with Advocacy!

Staff  |  November 1, 2009

Personal stories are the most effective way to communicate an issue to Congress. No one can better illustrate the complex nature of healthcare policy decisions and how they affect medical care than those involved daily in the medical profession.

  • « Previous Page
  • 1
  • …
  • 283
  • 284
  • 285
  • 286
  • 287
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences